MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

Search

Fortress Biotech Inc

Aperta

2.73 -2.5

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.68

Massimo

2.83

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+417.86% upside

Dividendi

By Dow Jones

Utili prossimi

12 nov 2025

Fortress Biotech Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

1 ott 2025, 15:07 UTC

I principali Market Mover

Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility

10 mar 2025, 02:12 UTC

Acquisizioni, Fusioni, Takeovers

Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY

10 mar 2025, 02:12 UTC

Acquisizioni, Fusioni, Takeovers

Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY

10 mar 2025, 02:11 UTC

Acquisizioni, Fusioni, Takeovers

Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY

10 mar 2025, 02:11 UTC

Acquisizioni, Fusioni, Takeovers

Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY

10 mar 2025, 02:10 UTC

Acquisizioni, Fusioni, Takeovers

Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY

10 mar 2025, 02:10 UTC

Acquisizioni, Fusioni, Takeovers

Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT

10 mar 2025, 02:06 UTC

Acquisizioni, Fusioni, Takeovers

Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT

Confronto tra pari

Modifica del prezzo

Fortress Biotech Inc Previsione

Obiettivo di Prezzo

By TipRanks

417.86% in crescita

Previsioni per 12 mesi

Media 14.5 USD  417.86%

Alto 17 USD

Basso 12 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Fortress Biotech Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

2 ratings

2

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

$

help-icon Live chat